PHARMACEUTICAL PRODUCTS IN NATURE

Brand Owner (click to sort) Address Description
CALAN WYETH HOLDINGS 235 East 42nd Street New York NY 10017 PHARMACEUTICAL PRODUCTS IN THE NATURE OF CALCIUM ANTAGONISTS FOR THE TREATMENT OF CARDIOVASCULAR CONDITIONS;FIRST USED IN ANOTHER FORM ON JANUARY 9, 1981;
MAXAQUIN G. D. SEARLE & CO. Skokie IL PHARMACEUTICAL PRODUCTS IN THE NATURE OF ANTI-INFECTIVE DRUGS;
NORETHIN G. D. SEARLE & CO. Skokie IL PHARMACEUTICAL PRODUCTS IN THE NATURE OF ORAL CONTRACEPTIVES;
OMNIQUIN G. D. SEARLE & CO. Skokie IL PHARMACEUTICAL PRODUCTS IN THE NATURE OF ANTI-INFECTIVE DRUGS;
UNIQUIN G. D. SEARLE & CO. Skokie IL PHARMACEUTICAL PRODUCTS IN THE NATURE OF ANTI-INFECTIVE DRUGS;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Media and processes for the fermentation of Clostridium botulinum and obtaining a botulinum toxin for use in formulating botulinum toxin pharmaceutical compositions. The growth media can contain significantly reduced levels of meat or dairy by-products using non-animal based products to replace the animal-derived products. Preferably, the media used are substantially free of animal derived products.